ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Research Reagent/N-fmoc-L-norleucine
C21H23NO4
353.4 g/mol
Research ReagentWarning

(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)hexanoic acid

CAS77284-32-3EC692-798-8
Category
Research Reagent
Compound Class
Peptide
Primary Use
Research Compound

This compound is an Fmoc-protected derivative of L-norleucine, a building block used in solid-phase peptide synthesis. Its significance lies in its role as a research reagent for incorporating norleucine residues into synthetic peptides.

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

StrongStructure SimilarSimilarity 0.86

Fmoc-L-Norvaline

CAS135112-28-6

pharmaceutical intermediate

SimilarStructure SimilarSimilarity 0.77

Fmoc-L-lysine

CAS105047-45-8

pharmaceutical intermediate

SimilarStructure SimilarSimilarity 0.77

Nalpha-Fmoc-L-lysine hydrochloride

CAS139262-23-0

pharmaceutical intermediate

SimilarStructure SimilarSimilarity 0.77

N2-[(9H-Fluoren-9-ylmethoxy)carbonyl]-D-lysine hydrochloride

CAS201002-47-3

pharmaceutical intermediate

ApplicationSame Use

Fmoc-L-tert-leucine

CAS132684-60-7

research compound

ApplicationSame Use

N-Fmoc-L-Glutamine

CAS71989-20-3

research compound

ApplicationSame Use

Fmoc-D-proline

CAS101555-62-8

research compound

ApplicationSame Use

Fmoc-N-methyl-D-leucine

CAS103478-63-3

research compound

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more

Safety Reference

Harmful
Harmful
Warning
H315Causes skin irritation
H319Causes serious eye irritation
H332Harmful if inhaled
H335May cause respiratory irritation
Identifiers
IUPAC Name

(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoic acid

InChIKey

VCFCFPNRQDANPN-IBGZPJMESA-N

SMILES

CCCC[C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13

Synonyms (16)
  • Fmoc-Ahx-OH
  • Fmoc-L-2-aminohexanoic acid
  • Fmoc-L-Nle-OH
  • Fmoc-L-norleucine
  • Fmoc-L-norleucine Fmoc-Nle-OH
  • Fmoc-Nle
  • Fmoc-Nle-OH
  • Fmoc-norleucine
  • N-Fmoc-L-norleucine

Sourcing this compound?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→